FDA Investigator Gina Eng
Gina Eng has conducted inspections on 42 sites in 1 countries as of 25 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
42
Last Inspection Date:
25 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gina Eng:
Aaron F Coleman,
Abdellah El Hajjam,
Ana P Barido,
Angela E Glenn,
Ashley Gonzalez,
Bruce Quijano,
CDR Sean T Creighton,
Chyla T Hunter,
Clara E Santiago,
Courtney A Gilbert,
Courtney Hunt,
David P King,
Dusty F Snoeberg,
Earl Echon,
Eric R Holm,
Ethan P Stegman,
Frances M Rivera,
Gerard D Difiore,
German Rivera,
Gina C Chen,
Glenn S Quintanilla,
Heather M Roach,
James To Neal,
Jennifer A Robinson,
Jennifer L Huntington,
Jennifer M Menendez,
Jessica L Pressley,
Juan C Gonzalez Rivera,
Karen L Anderson,
Karissa J Mccaw,
Karl D Hezel,
Laura M Lopez,
Leroy Terrelonge,
Leyden Guerrero,
Linda K Matheny,
LT Prince D Brown,
LT Tamara J Henderson,
Lura D Kelly,
Marc Balzarini,
Marinee Flores Marrero,
Mary F Bodick,
Matthew B Thomaston,
Mendoza,
Michelle S Dunaway,
Minerva Rogers,
Neimar Lopez,
Norton,
Ormond,
Patrick J Legler,
Paul A Licata,
Paul H Dakin,
Raymond A Lyn, Jr,
Reynolds,
Ronan F King,
Sandra Carpio,
Sharon Giamberini,
Sherbet L Samuels,
Sheri L Stephenson,
Sondra R Davis,
Steven A Brettler,
Susan M Turcovski,
Victor Spanioli,
Yazmith Guzman
Gina Eng's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2021 | FDA 483 | Dilip Ceramics Inc. dba Shivam Distributors - Form 483, 2021-01-06 |
October, 2019 | FDA 483 | Hollywood Health Products, Inc. - Form 483, 2019-10-11 |
August, 2021 | EIR | Arizona Nutritional Supplements LLC - EIR, 2021-08-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more